Demetra and Masmec Biomed announce strategic collaboration in surgical AI and navigation

[Milan, 22 July 2026] Demetra Holding announces a strategic collaboration with Masmec Biomed, an Italian company specialized in the development of advanced surgical navigation systems, artificial intelligence, and high-complexity medical technologies. The initiative is part of Demetra’s broader strategy to move beyond the traditional boundaries of medical devices and actively contribute to the transformation of surgery.

A European platform for clinical and technological innovation

The collaboration reflects a deliberate shift in Demetra’s strategic direction. In recent years, the Group has strengthened its position across the orthopaedic, neuro, and spine sectors, building an increasingly comprehensive portfolio and expanding its international footprint. Today, building on that established clinical leadership, Demetra is investing in the technologies that are reshaping surgery: AI, surgical navigation, robotics, and data-driven clinical tools.

The market context

Surgical navigation and AI-based applications represent one of the highest-growth areas in MedTech. Adoption across many procedures remains limited today, pointing to significant development potential across multiple surgical disciplines in the years ahead.

In this context, Demetra aims to establish itself as a European platform for clinical and technological innovation, capable of identifying, connecting, and enhancing expertise across the sector while accelerating the adoption of advanced solutions.

Complementary strengths, shared direction

The partnership is built on a clear complementarity of competencies. Demetra contributes clinical leadership, an established international presence, and deep knowledge of surgical market needs across orthopaedics, spine, and neuro. Masmec Biomed brings advanced engineering expertise, artificial intelligence capabilities, and experience in surgical navigation developed across high-innovation industries.

A shared conviction about the future of surgery

This collaboration reflects a conviction shared by both organizations: the future of surgery will not be defined solely by new implants, materials, or techniques. Progress will be driven by the ability to integrate clinical knowledge, data, software, AI, and advanced technologies into a unified ecosystem capable of improving every phase of the care pathway.

Together, the two organizations will explore new opportunities in enabling technologies for surgery, with a shared focus on precision, data integration, and predictive clinical capability.

“Demetra’s story began in operating rooms, alongside surgeons. That is still where we look to understand the future. A new generation of technologies will make surgery more precise, more predictive, and increasingly personalized. Such a transformation requires a new industrial model, capable of connecting clinical expertise, artificial intelligence, navigation, robotics, and data. Our ambition is not simply to participate in this change. It is to help build it.”

Michele Perrino, CEO, Demetra Holding

A partnership built on shared ambition

For Masmec Biomed, the collaboration represents both a validation of its work and a new context for growth.

“Being chosen by Demetra is a great pride for us and confirms the value of the work we have carried out over the years. We share the same vision and ambition: increasingly personalized care enabled by technology that ensures accurate diagnosis, minimally invasive procedures, and an approach centered on patient respect and healthcare system sustainability. Demetra offers the solidity and authority of a well-established market player, while Masmec brings continuous innovation and a relentless pursuit of quality. This is where we find the space to continue innovating, with a partner capable of giving scale and perspective to our work.”

Daniela Vinci, CEO, Masmec

The next step in Demetra’s journey

Through this collaboration, Demetra continues its evolution from a leader in the spine and orthopaedic sector to a promoter of a new paradigm for European MedTech, one in which surgery, data, artificial intelligence, and innovation converge to build the next generation of care.

“The most relevant companies of the next decade will not be those that simply produce better technologies, but those capable of creating ecosystems where innovation, knowledge, and expertise work together to generate value. This is the future we are building: not a single product, but a new generation of solutions for surgery.”